References
- Driggin E, Madhavan MV Bikdeli B, et al. Cardiovascular considerations
for Patients, Health Care Workers, and Health systems during the
Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol 2020
Mar 18 [Epub ahead of print].
- Saleh M, Gabriels J, Chang D, et al. The effect of chloroquine,
hydroxychloroquine and azithromycin on the corrected QT interval in
patients with SARS-CoV-2 Infection. Circ Arrhythm Electrophysiol 2020;
April 29 [Epub ahead of print].
- Tisdale JE, Jaynes HA, Kingery JR et al. Development and validation of
a risk score to predict QT interval prolongation in hospitalized
patients. Circ Cardiovasc Qual Outcomes 2013;6(4):479-87.
- Chang D, Saleh M, Gabriels J, et al. Inpatient use of ambulator
telemetry mointors for COVID-19 patients treated with
hydroxychloroquine and/or azithromycin. JACC 2020 [Epub ahead of
print].
- Wosik J et al. Telehealth Transformation: COVID-19 and the rise of
virtual care. J Am Med Inform Assoc 2020 Apr 20 [Epub ahead of
print].
- Dorr M, Nohturfft V, Braiser N, et al. The Watch AF Trial:
SmartWatches for Detection of Atrial fibrillation. JACC Clin
Electrophysiol 2019(2):199-209.
- Saghir N, Aggarwal A, Soneji N, et al. Apple watch series 4 vs.
12-lead ECG: A comparison of manual electrocardiographic waveform
analysis. JACC 2020;75(11)S1 (“abstr”).
- Garabelli P, Stavrakis S, Albert M, et al. Comparison of QT interval
readings in normal sinus rhythm between a smartphone heart monitor and
a 23-lead ECG for healthy volunteers and inpatients receiving sotalol
or dofetilide. J Cardiovasc Electrophysiol 2016;27(7);827-832.
- Cheung C, Davies B, Gibbs K, Laksman ZW, Krahn AD. Multi-lead QT
screening is necessary for QT measurement: Implications for management
of patients in the COVID-19 Era. JACC: Clinic Electrophysiol 2020
[Epub ahead of print].
- Darbar D, Kimbrough J, Jawaid A, McCray R, Ritchi MD, Roden DM.
Persistent atrial fibrillation is associated with reduced risk of
torsades de pointes in patients with drug-drug induced long QT
syndrome. JACC 2008;51(8);836-42.
- Salvi V, Karnad DR, Kerkar V, et al. Choice of an alternative lead for
QT interval measurement in serial ECGs when lead II is not suitable
for analysis. Indian Heart J 2012;64(6):535-40.